Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Financings in Brief: ThermoLase

This article was originally published in The Gray Sheet

Executive Summary

ThermoLase: Announces Aug. 18 that it has commenced a public offering of 2.3 mil. common shares of its stock, to be sold for $25.25 each. The San Diego-based firm's offering is being managed by NatWest Securities Limited, Lehman Brothers, and Oppenheimer & Co. ThermoLase, which received clearance earlier this year for its laser-based hair removal system, says that proceeds from the offering will be used for further commercialization of the system. The company is preparing to open a hair removal center in La Jolla, California toward the end of this year. Underwriters have a 30-day over-allotment option to purchase 337,500 shares, ThermoLase says...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT004558

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel